Frauke Pohlki

Frauke Pohlki is Director in Global Medicinal Chemistry within Early Research and Development at AbbVie Deutschland GmbH & Co. KG and oversees the small molecule Neuroscience and Ophthalmology portfolio. Frauke has over 17 years of experience in Drug Discovery and focusses on innovative approaches for neurological diseases, including Alzheimer’s, Parkinson’s, migraine, and schizophrenia, as well as unmet medical needs in eye care to make a meaningful impact on patients' lives. Frauke holds a PhD in organic chemistry from the University of Heidelberg.